Skip to main content
    B

    Bone Biologics Corp (BBLG)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $0.39
    -0.03 (-6.51%)

    Market Cap: $1.13M

    Last updated: Oct 16, 2026 at 1:54 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    70%(14/20)
    Avg Surprise
    -2.32%

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.19
    Range$-0.19 - $-0.19
    1 analysts
    EPS RevisionsNo revisions (7d)
    0
    1
    30d
    EPS Estimate DriftChange to current
    90d ago$-0.36+47.2%
    60d ago$-0.36+47.2%
    30d ago$-0.18-5.6%
    7d ago$-0.18-5.6%
    Current$-0.19
    Revenue Consensus
    $0
    Range$0 - $0
    1 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-0.11
    Range$-0.11 - $-0.11
    1 analysts
    Revenue Consensus
    $0
    Range$0 - $0
    1 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.11---
    Sep 26EST
    		-$-0.19---
    Jun 26
    Reported Aug 14
    		$-0.43$-0.39-10.26%Miss+67.7%
    Mar 26
    Reported May 14
    		$-0.43$-0.54+20.37%Beat-34.6%
    Dec 25
    Reported Mar 2
    		$-0.63$-0.34-85.29%Miss+78.1%
    Sep 25
    Reported Nov 14
    		$-0.37N/A+69.92%Beat+97.4%
    Jun 25
    Reported Aug 14
    		$-1.33$-0.58-129.31%Miss+66.9%
    Mar 25
    Reported May 12
    		$-0.32N/A+95.84%Beat+95.9%
    Dec 24
    Reported Mar 5
    		$-2.88$-3.90+26.15%Beat-16.6%
    Sep 24
    Reported Nov 14
    		$-14.22$-3.60-295.00%Miss+51.4%
    Jun 24
    Reported Aug 9
    		$-4.02N/A+51.80%Beat+95.0%
    Mar 24
    Reported Apr 4
    		$-7.86N/A+82.76%Beat+97.6%
    Dec 23
    Reported Feb 20
    		$-2.47N/A+55.89%Beat-1272.2%
    Sep 23
    Reported Nov 14
    		$-29.28N/A+79.93%Beat+83.1%
    Jun 23
    Reported Aug 14
    		$-81.12$-72.00-12.67%Miss-12.7%
    Mar 23
    Reported May 15
    		$-331.20$-100.80-228.57%Miss-228.6%
    Dec 22
    Reported Mar 30
    		$-0.18$-0.22+18.18%Beat-260.0%
    Sep 22
    Reported Nov 14
    		$-172.80$-216.00+20.00%Beat-101547.1%
    Jun 22
    Reported Aug 11
    		$-72.00N/A+58.33%Beat-102757.1%
    Mar 22
    Reported May 13
    		$-100.80N/A+65.00%Beat-167900.0%
    Dec 21
    Reported Mar 15
    		$-0.05N/A+70.59%Beat+99.9%
    Sep 21
    Reported Nov 16
    		$-0.17$-0.17+0.00%Beat+99.9%
    Jun 21
    Reported Aug 16
    		$-0.07N/AN/ABeat+100.0%
    Mar 21
    Reported Apr 15
    		$-0.06N/AN/ABeat+100.0%
    Dec 20
    Reported Dec 31
    		$-53.23N/AN/ABeat-75948.7%
    Sep 20
    Reported Sep 30
    		$-194.90N/AN/ABeat-243530.0%
    Jun 20
    Reported Jun 30
    		$-187.97N/AN/ABeat-144492.2%
    Mar 20
    Reported Mar 31
    		$-295.24N/AN/ABeat-155288.4%
    Dec 19
    Reported Mar 27
    		$-0.07N/AN/ABeat+81.6%
    Sep 19
    Reported Nov 14
    		$-0.08N/AN/ABeat-166.7%
    Jun 19
    Reported Aug 14
    		$-0.13N/AN/ABeat+55.2%
    Mar 19
    Reported May 13
    		$-0.19N/AN/ABeat-216.7%
    Dec 18
    Reported Mar 29
    		$-0.38N/AN/ABeat+100.0%
    Sep 18
    Reported Nov 16
    		$-0.03N/AN/ABeat+50.0%
    Jun 18
    Reported Aug 14
    		$-0.29N/AN/ABeat-1550.0%
    Mar 18
    Reported Apr 2
    		$-0.06N/AN/ABeat+25.0%
    Dec 17
    Reported Dec 31
    		$-2160.00N/AN/ABeat+52.2%
    Sep 17
    Reported Nov 14
    		$-0.06N/AN/ABeat-
    Jun 17
    Reported Aug 8
    		$0.02N/AN/ABeat-
    Mar 17
    Reported May 12
    		$-0.08N/AN/ABeat-
    Dec 16
    Reported Mar 29
    		$-4523.44N/AN/ABeat-

    Key Metrics

    Valuation
    P/E Ratio-0.21EV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-55.00%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio8.67xQuick Ratio8.67x
    Trading Statistics
    Beta0.57Avg Volume280.95K
    52-Week High$2.6652-Week Low$0.39

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$0.46
    SMA 20$0.47
    SMA 50$0.57
    SMA 200$1.13
    EMA 10$0.45
    EMA 20$0.48
    EMA 50$0.61
    EMA 200$1.19

    MACD

    Line: -0.05Signal: -0.05Hist: -0.00

    ADX

    ADX: 43.9+DI: 9.0-DI: 27.4

    Aroon & PSAR

    Aroon Up12.0
    Aroon Down100.0
    PSAR$0.53

    Bollinger Bands

    Upper Band$0.54
    Lower Band$0.41
    %B Position2677%(Upper)
    Band Width-0.18

    RSI (14-Day)

    Oversold
    19.2

    Momentum Oscillators

    Stoch %K16.6
    Stoch %D16.6
    Williams %R-92.5
    ROC (10d)-18.4%
    Momentum-0.09
    CCI (20d)-258.4
    MFI (14d)23.1

    Volatility Measures

    ATR (14d)$0.04(9.9%)
    StdDev (20d)0.03
    Hist Vol54.2%(High)

    Volume Flow

    VWAP$0.39
    OBV145.9M
    AD Line287.1M
    CMF (20d)0.052

    Volume Metrics

    Avg Vol (20d)76.7K
    Vol Ratio1.5x(High)
    VWMA (20d)$0.48

    Pivot Points

    R3$0.45
    R2$0.44
    R1$0.42
    Pivot Point$0.41
    S1$0.40
    S2$0.38
    S3$0.37

    Advanced Oscillators

    TSI-47.34
    Ultimate Osc49.3
    KST-178.60

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$0$0$0$0$0$0$0$0$0$0$0$0
    Cost of RevenueN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A$0
    Gross Profit$0N/AN/AN/A$0N/AN/A$0N/AN/AN/A$0
    Operating Expenses$808,106$805,054$733,107$715,274$748,075$1.04M$1.55M$951,021$809,665$903,536$1.16M$2.08M
    R&D$308,747$141,597$257,199$187,808$191,608$423,576$1.10M$429,747$350,442$245,625$447,077$1.57M
    SG&A$499,359$663,457$475,908$527,466$556,467$614,910$450,368$521,274$459,223$657,911$712,931$506,040
    Operating Income$-808,106$-805,054$-733,107$-715,274$-748,075$-1,038,486$-1,554,938$-951,021$-809,665$-903,536$-1,160,000$-2,081,000
    Interest Income$34,512$38,801$47,964$47,325$6,654$20,039$20,264$19,993$15,147$255$349$536
    Interest Expense$0$0$0$0$0$0$0$0$0$0$562,362$0
    Income Before Tax$-773,702$-765,988$-684,643$-666,737$-740,519$-1,017,092$-1,521,715$-941,002$-783,733$-865,970$-1,550,000$-1,920,000
    Income Tax Expense$0$0$0$0$0$0$903,536$0$-809,665$-904,000$-349$-2,080
    Net Income$-773,702$-765,988$-684,643$-666,737$-740,519$-1,017,092$-1,521,715$-941,002$-783,733$-865,970$-1,550,000$-1,920,000
    EBITDA$-773,702$-765,988$-677,087$48,537$-740,519$-1,017,092$-1,521,715$-941,002$-783,733$-865,970$-389,992$160,890
    EBIT$-808,106$-805,054$-677,087$-666,737$-748,075$-1,038,000$-1,554,000$-891,021$-810,000$-796,536$-1,550,000$-1,920,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about BBLG

    News

    Form 25-NSE Bone Biologics Corp Filed by: Nasdaq Stock Market LLC

    Nasdaq Stock Market LLC has filed a Form 25-NSE regarding Bone Biologics Corp. This filing is a standard SEC document related to the delisting of securities from an exchange. The article provides access to the primary...

    StreetInsider•10/13/26•Neutral

    Form 4 Bone Biologics Corp For: 1 October By Investing.com

    This article from Investing.com reports on a Form 4 filing for Bone Biologics Corp, dated October 1. The brief mention indicates a financial disclosure event for the company, BBLG.

    Investing.com South Africa•10/2/26•Neutral

    Form 4 Bone Biologics Corp For: 1 October By Investing.com

    This article from Investing.com reports the filing of Form 4 by Bone Biologics Corp on October 1st. Form 4 is a document filed with the SEC to disclose changes in beneficial ownership of securities by company insiders....

    Investing.com Nigeria•10/1/26•Neutral

    114K options with a $0.50 exercise price go to Bone Biologics (BBLG) director Bruce Stroever.

    Bone Biologics Corp (BBLG) director Bruce Stroever received a grant of 113,896 non-employee stock options on September 28, 2026. These options have an exercise price of $0.50 per share and expire on September 28...

    Stock Titan•10/1/26•Neutral

    Form 4 Bone Biologics Corp For: 30 September By Investing.com

    This article reports on the filing of Form 4 by Bone Biologics Corp for the period ending September 30. It includes the stock symbol BBLG and its performance...

    Investing.com Nigeria•9/30/26•Neutral

    BBLG Valuation and Fair Value

    P/E
    -0.2x
    PEG
    0.0x
    P/B
    0.2x
    See GNG's fair value

    BBLG Profitability: Margins, ROIC and FCF

    Operating margin
    0.0%
    Net margin
    0.0%
    ROE
    -55.0%

    BBLG Competitors

    CompanyTicker
    Scinai Immunotherapeutics LtdSCNI
    GlucoTrack IncGCTK
    VSee Health, Inc.VSEE
    SAB Biotherapeutics IncSABSW
    Mobile-health Network Solutions Class A Ordinary SharesMNDR
    Profusa, Inc. Common StockPFSA
    Iterum Therapeutics PLCITRM
    Venus Concept IncVERO

    Sector: Healthcare

    BBLG Earnings: Beat Rate and Next Report

    Beat rate
    4 of 8 quarters (50.0%)
    Average surprise
    -38.4%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-0.19
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    0 up, 1 down

    Frequently Asked Questions About BBLG

    Does BBLG pay dividends?

    Bone Biologics Corp (BBLG) does not currently pay a regular dividend.

    What is BBLG's market cap?

    Bone Biologics Corp (BBLG) has a market capitalization of $1.13M with a current stock price of $0.39.

    Related stocks

    Sector: Healthcare

    All stocks starting with B

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In